Pharma giant Bayer will invest $2.2B in a New Albany, Ohio manufacturing campus for oncology and cardiovascular drugs, ...

Earlier this month, DaltonTx, an AI company specializing in the biotechnology sector, announced the expansion of its ...

Bio-Techne's new Bristol facility strengthens its cell therapy supply chain with GMP small molecule production, complementing ...

From scale-up pitfalls to tech transfer nightmares, learn how emerging biotech companies can avoid costly mistakes when ...

HPLC continues to meet such demands through advances in column chemistry, instrument performance, and software, allowing laboratories to characterize increasingly complex molecules with greater ...

Helping Downstream Processing To Follow Upstream Innovation. Complex biomolecules place unprecedented demands on conventional ...

Examine the use of CHT™ XT Media, a ceramic hydroxyapatite mixed-mode resin, to facilitate purification of various large ...

Learn strategies for controlling trace metals, polysorbate degradation, and other key formulation risks that can compromise ...

Allogeneic cell therapies offer scalability but require expanded infrastructure to build a viable commercial foundation ...

The IND pilot is part of the HHS's ongoing mission to onshore clinical trials.

Drug sponsors seek to capitalize on opportunities created by streamlined regulations for biosimilar characterization.

Rationalizing Biological Drug Development: Biosimilar Science, Modality-Specific Pathways, and the Bioprocessing Revolution, Part 1 Regulatory frameworks for biosimilars were developed two decades ago ...